Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiolabeled2{beta}-carbo-2{prime}(S)-fluoroisopropoxy-3{beta}-(4-iodophenyl)-tropane (FIPIT): Synthesis, characterization and primate imaging of a radioligand for mapping dopamine transporter sites by both PET and SPECT

Journal Article · · Journal of Nuclear Medicine
OSTI ID:447783
; ;  [1]
  1. Emory Univ., Atlanta, GA (United States); and others

Highly potent and selective dopamine transporter ligands containing both iodine and fluorine are versatile probes for in vivo mapping of dopamine transporter sites in the striatum by PET and SPECT when labeled with fluorine-18 and iodine-123, respectively. Dual labeled biochemical probes are attractive agents since only one set of toxicity and pharmacokinetic analysis may be required for ligand validation for both imaging modalities. Recently, we reported that replacement of the methyl ester of 2{beta}-carbomethoxy-3{beta}-(4-chlorophenyl)tropane with a 2{prime}(R,S)-[F-18]fluoroisopropyl ester affords a highly potent and selective dopamine transporter ligand, 2{beta}-carbo-2{prime}(R,S)- fluoroisopropoxy-3{beta}-(4-chlorophenyl)tropane (FIPCT). FIPCT showed high uptake and retention in the striatum (S) resulting in good S/cerebellum = 3.5 at 125 min post injection in a rhesus monkey. These findings prompted us to synthesize and evaluate the 4-iodo analog, 2{beta}-carbo-2{prime}-(S)-fluoroisopropoxy-3{beta}-(4-iodophenyl)tropane (1) with 1-fluoropropan-2-ol (2) and POC13. These results suggest that [F-18]S-FIPIT is an excellent candidate for mapping of dopamine transporter sites.

OSTI ID:
447783
Report Number(s):
CONF-960659--
Journal Information:
Journal of Nuclear Medicine, Journal Name: Journal of Nuclear Medicine Journal Issue: Suppl.5 Vol. 37; ISSN 0161-5505; ISSN JNMEAQ
Country of Publication:
United States
Language:
English